UBS Group AG - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 88 filers reported holding SURFACE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q2 2023$5,981
-45.9%
6,875
-56.5%
0.00%
Q1 2023$11,048
+62.1%
15,805
+90.1%
0.00%
Q4 2022$6,817
-89.5%
8,313
-86.6%
0.00%
Q3 2022$65,000
-78.1%
62,127
-65.6%
0.00%
Q2 2022$297,000
+25.8%
180,682
+124.6%
0.00%
Q1 2022$236,000
-41.0%
80,436
-4.0%
0.00%
Q4 2021$400,000
+198.5%
83,791
+375.7%
0.00%
Q3 2021$134,000
+26.4%
17,615
+23.4%
0.00%
Q2 2021$106,000
+17.8%
14,269
+24.4%
0.00%
Q1 2021$90,000
+30.4%
11,466
+52.9%
0.00%
Q4 2020$69,000
+3350.0%
7,500
+480.9%
0.00%
Q3 2019$2,000
-83.3%
1,291
-47.7%
0.00%
Q1 2019$12,000
+33.3%
2,470
+20.9%
0.00%
Q4 2018$9,000
-90.2%
2,043
-75.7%
0.00%
Q3 2018$92,000
+283.3%
8,395
+466.5%
0.00%
Q2 2018$24,0001,4820.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$2,061,8179.68%
DAFNA Capital Management LLC 1,100,000$768,6800.23%
TANG CAPITAL MANAGEMENT LLC 1,300,000$908,4400.14%
EcoR1 Capital, LLC 3,082,959$2,154,3720.07%
ARK Investment Management 5,496,146$3,840,7070.03%
Forefront Analytics, LLC 61,156$42,7370.02%
GSA CAPITAL PARTNERS LLP 230,292$1610.02%
CORNERCAP INVESTMENT COUNSEL INC 113,219$79,1170.01%
Knights of Columbus Asset Advisors LLC 157,769$110,2490.01%
Nikko Asset Management Americas, Inc. 999,026$649,3670.01%
View complete list of SURFACE ONCOLOGY INC shareholders